Ashok Kumar Jain’s Stock Portfolio: Holdings & Bets
Ashok Kumar Jain’s Portfolio Value and Recent Performance
Ashok Kumar Jain’s disclosed public shareholding portfolio, filed with associates as is common under Indian shareholding norms, is worth Rs 488.71 crore across 36 stocks. That is up 22.38% over the previous quarter, according to Trendlyne’s Superstar Portfolio tracker.
With 36 disclosed holdings on a portfolio of this size, the average position size is relatively small, suggesting a strategy built around spreading bets across many smaller companies rather than concentrating heavily in just a few names.
What Sectors Does Ashok Kumar Jain Invest In?
Financial services leads the portfolio by a wide margin, followed by consumer and agricultural inputs themes.
| Sector | Weight |
|---|---|
| Banking and Finance | 47.63% |
| Consumer Durables | 15.97% |
| Fertilizers | 10.92% |
Nearly half the disclosed portfolio sits in banking and finance, a common theme among Indian retail and value-oriented investors given the sector’s size and long growth runway. The fertilizers exposure at 10.92% is a somewhat distinctive addition, tying part of the portfolio to India’s agricultural input demand cycle.
Consumer durables at close to 16% adds a domestic consumption angle, a sector that tends to benefit from rising household incomes and discretionary spending. Together, these three sectors give the portfolio a blend of financial services growth, agricultural input demand, and consumer spending themes, spanning quite different parts of the economy despite the concentration in the top name.
Top Holdings in Ashok Kumar Jain’s Portfolio
Three names stand out among the 36 disclosed holdings:
- Arihant Capital Markets (Rs 228.55 crore) – a broking and financial services company offering equity trading, wealth management, and related services, fitting squarely within the banking and finance sector weighting.
- Fluidomat (Rs 78.0 crore) – a manufacturer of fluid couplings and industrial power transmission equipment used across sectors like cement, steel, and mining.
- Madhya Bharat Agro Products (Rs 52.14 crore) – a company involved in agrochemicals and agricultural inputs, aligning with the fertilizers sector exposure in the portfolio.
Arihant Capital Markets alone accounts for close to 47% of the entire disclosed Rs 488.71 crore portfolio, a very high concentration for a single stock within a 36 stock portfolio. This means the remaining 35 stocks combined make up just over half the total value, with many likely being fairly small individual positions.
What Has Ashok Kumar Jain Bought and Sold Recently?
The latest quarterly filings show a mix of fresh buying and one notable reduction.
Recently bought:
– Dipna Pharmachem, a new stake of 9.59%
– Le Lavoir Aromatics, a new stake of 6.34%
– Viji Finance, a new stake of 1.87%
Recently sold (trimmed):
– Fluidomat, reduced by 3.0%
The Fluidomat trim is notable since the stock is also one of the top three disclosed holdings. Reducing a stake by 3% in a name that still ranks among the largest positions suggests partial profit booking or portfolio rebalancing, rather than a full exit from the position.
The new stakes in Dipna Pharmachem and Le Lavoir Aromatics bring pharmaceutical intermediates and aroma or fragrance chemical exposure into the portfolio, both niche manufacturing segments that occasionally attract investor interest for their export potential and specialized product lines.
What Does This Portfolio Style Suggest?
A portfolio spanning 36 stocks but dominated by one large position tells an interesting story about how capital may be allocated here.
A Core Holding With a Wide Satellite Book
Arihant Capital Markets functions as a clear core, anchor holding, while the remaining 35 stocks look more like a satellite book of smaller, exploratory positions across various sectors and company sizes. This barbell style, one large conviction bet plus many smaller ones, is a recognizable pattern among some retail and family office style investors.
Comfort With Small and Microcap Names
Given the size of holdings like Fluidomat and Madhya Bharat Agro Products, and the fresh smaller stakes in Dipna Pharmachem and Le Lavoir Aromatics, this portfolio leans toward smaller, less widely tracked companies rather than large cap, index heavyweight stocks.
Active Rebalancing Around a Core Position
The Fluidomat trim alongside continued new buying elsewhere shows this is not a passive, buy and forget portfolio. Capital appears to be actively reallocated across the 36 holdings as new opportunities and profit booking decisions arise each quarter.
What This Data Does Not Show
As with every Superstar Portfolio snapshot, there are real gaps to account for before drawing conclusions.
- The 1% disclosure threshold hides smaller stakes. Positions below that mark, along with mutual funds, bonds, or other assets, are simply not part of this data.
- Quarterly filings introduce a reporting lag. Actual positions could have shifted in the time since the last disclosure date.
- Entry price and purchase timing are unknown. We cannot judge whether the Fluidomat trim locked in a gain or simply reduced exposure at a loss.
- Joint or associate filings can combine multiple individuals. As is standard practice, this portfolio is filed with associates, so the ownership split within the group is not separately broken out.
Why This Data Is Still Worth Tracking
Despite these limitations, following a portfolio like this offers genuine research value:
- It highlights smaller, less followed companies like Fluidomat and Madhya Bharat Agro Products that may be overlooked by mainstream analyst coverage.
- The mix of a dominant core holding with many smaller bets offers a template worth studying for its risk and diversification balance.
- Fresh additions in niche segments like pharmaceutical intermediates and aroma chemicals can point to emerging themes worth researching further.
As with any Superstar Portfolio data, the smartest way to use this is as a research prompt rather than a shopping list. Looking into why a broking company like Arihant Capital Markets has grown into such a large position, and whether that growth reflects the business’s own performance or simply price appreciation, will tell you far more than the raw rupee figures alone.
Summary
Ashok Kumar Jain’s disclosed portfolio, filed with associates, is worth Rs 488.71 crore across 36 stocks, up 22.38% this quarter. It is anchored by Arihant Capital Markets, Fluidomat, and Madhya Bharat Agro Products, with fresh buying in Dipna Pharmachem, Le Lavoir Aromatics, and Viji Finance, alongside a trim in Fluidomat.
FAQs
What is Ashok Kumar Jain’s total disclosed portfolio value?
The portfolio, filed with associates, is worth Rs 488.71 crore across 36 stocks, based on the latest quarterly shareholding data.
What is the largest holding in this portfolio?
Arihant Capital Markets is the largest disclosed holding at Rs 228.55 crore, making up close to 47% of the total portfolio value.
Why was Fluidomat both a top holding and a recent sale?
The portfolio trimmed 3% of its Fluidomat stake this quarter while the stock still remains one of the largest disclosed holdings, suggesting partial profit booking rather than a full exit.
What new stocks were added to the portfolio recently?
Fresh stakes were disclosed in Dipna Pharmachem, Le Lavoir Aromatics, and Viji Finance in the most recent quarterly filing.
Why does this portfolio hold 36 stocks if one name dominates the value?
This barbell structure, with one large core holding and many smaller positions, is a common style where an investor keeps a dominant conviction bet while exploring smaller opportunities across other sectors.
Key Takeaways
- Ashok Kumar Jain’s disclosed portfolio (with associates) is worth Rs 488.71 crore across 36 stocks.
- The portfolio rose 22.38% in value this quarter.
- Banking and Finance makes up 47.63% of the portfolio, led by Arihant Capital Markets.
- Other top holdings include Fluidomat and Madhya Bharat Agro Products.
- Recent buys include Dipna Pharmachem, Le Lavoir Aromatics, and Viji Finance.
- Fluidomat was trimmed by 3% this quarter despite remaining a top holding.
- The portfolio shows a core-and-satellite style, with one dominant stock and many smaller positions.
